<?xml version="1.0" encoding="UTF-8"?>
<p>Disease in equids is generally more severe than humans with case fatality rates ranging from 10 to 50% [
 <xref rid="B139-microorganisms-08-01167" ref-type="bibr">139</xref>]. Following a one- to three-week incubation period, febrile signs will manifest early in the disease progression including fever, anorexia, restlessness, irritability, decreased movement, and ataxia [
 <xref rid="B139-microorganisms-08-01167" ref-type="bibr">139</xref>]. Subsequent neurological involvement can manifest as head pressing, stupor, head drooping, blindness, flaccid lips, involuntary movements, inability to stand, partially closed eyelids, convulsions, and paralysis. Terminally the animal can exhibit involuntary eye movement, paddling, and coma [
 <xref rid="B146-microorganisms-08-01167" ref-type="bibr">146</xref>]. A formalin-inactivated vaccine against WEEV is available for purchase and is routinely used to immunize horses against infection. Unfortunately the vaccine has low immunogenicity and requires annual boosters, though adequate coverage for affected areas can be achieved [
 <xref rid="B147-microorganisms-08-01167" ref-type="bibr">147</xref>].
</p>
